Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SKYE is expected to report earnings to rise 485.19% to -158 cents per share on November 05
Q3'26
Est.
$-1.58
Q2'26
Missed
by $0.02
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Missed
by $0.09
The last earnings report on August 18 showed earnings per share of -27 cents, missing the estimate of -24 cents. With 13.35K shares outstanding, the current market capitalization sits at 7.81M.